Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system
Published in
BMC musculoskeletal disorders, vol. 9, 165Publication date
2008Abstract
Keywords
- Anthraquinones/administration & dosage/adverse effects
- Antirheumatic Agents/*administration & dosage/adverse effects
- Calcitonin/administration & dosage/adverse effects
- Chondroitin Sulfates/administration & dosage/adverse effects
- Clinical Trials as Topic/*statistics & numerical data
- Etidronic Acid/administration & dosage/adverse effects/analogs & derivatives
- Glucosamine/administration & dosage/adverse effects
- Humans
- Hyaluronic Acid/administration & dosage/adverse effects
- Organometallic Compounds/administration & dosage/adverse effects
- Osteoarthritis/*drug therapy
- Outcome Assessment (Health Care)/methods
- Plant Extracts/administration & dosage/adverse effects
- Thiophenes/administration & dosage/adverse effects
UNIGE affiliation entities
UNIGE research groups
Citation (ISO format)
BRUYERE, Olivier et al. Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system. In: BMC musculoskeletal disorders, 2008, vol. 9, p. 165. doi: 10.1186/1471-2474-9-165
Main files (1)
Article (Published version)
Identifiers
- PID : unige:19012
- DOI : 10.1186/1471-2474-9-165
- PMID : 19087296
